Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal ATP Settings in the VT Zone for New Implantable Cardioverter Defibrillator (ICD) Implantation (DAN-ATP)

NCT07354347 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Rigshospitalet as lead sponsor.

NCT NCT07354347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07354347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal ATP Settings in the VT Zone for New Implantable Cardioverter Defibrillator (ICD) Implantation (DAN-ATP)
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2026
Completion date
July 31, 2041
Enrollment
3,980 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease, heart rhythm disorders, implantable cardioverter defibrillator (icd), ventricular tachyarrhythmias